全球环氧合酶 2抑制剂市场，按药物类型（塞来昔布、罗非昔布、伐地昔布、氨氯地平等）、类型（选择性 cox 2 抑制剂和非选择性 cox 2 抑制剂）、适应症（骨关节炎、类风湿性关节炎等）、给药途径（口服、肠外和其他）、最终用户（医院、专科诊所、其他）、分销渠道（医院药房、零售药房、其他）划分 - 行业趋势和预测到 2029 年。
市场分析和见解
非甾体抗炎药(NSAID) 因其解热、镇痛和抗炎作用而成为最广泛使用的治疗药物之一。环氧合酶 2 抑制剂是指非甾体抗炎药 (NSAID) 的一个子类，其作用是减少前列腺素的产生。前列腺素化学物质会引发疼痛、炎症和发烧。
环氧合酶 2 抑制剂或 COX-2 抑制剂用于治疗引起炎症、轻度至中度发烧和疼痛的疾病。Data Bridge Market Research 分析称，环氧合酶 2 抑制剂市场在 2022 年至 2029 年的预测期内预计将以 10.50% 的复合年增长率增长。
环氧合酶 2 抑制剂市场动态
驱动程序
- 关节炎的患病率
全球范围内骨关节炎、类风湿性关节炎等引起炎症和疼痛的疾病发病率的增加是推动环氧合酶2抑制剂市场增长的主要因素之一。
- 并购增加
制造商和研究机构之间的并购数量增加，以便为患者提供高效的医疗服务，并通过销售选择产生可观的收入，从而扩大市场。
- 疼痛管理
环氧合酶 2 抑制剂（如塞来昔布）由于其与其他 NSAID（如布洛芬、双氯芬酸和萘普生）一样有效减轻疼痛和炎症而得到广泛使用，这将有助于扩大市场。
- 为研究人员开发新干预措施提供资金支持
各种公共和私人组织正在加大对开发新干预措施和治疗方法的投资，以增强环氧合酶 2 抑制剂市场。
此外，对有效疗法的需求增加、技术的发展、医疗保健支出的激增、庞大的患者群体和先进的技术对环氧合酶 2 抑制剂市场产生了积极影响。
机会
Furthermore, advancements in the product to reduce the associated side-effects extends profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, research and development will escalate the growth of cyclooxygenase 2 inhibitor market.
Restraints/Challenges
On the other hand, high cost associated with the inhibitors and limited availability are expected to obstruct the market growth. The concerns regarding the side-effects such as risk of heart attacks and strokes with long term use are projected to challenge the cyclooxygenase 2 inhibitor market in the forecast period of 2022-2029.
This cyclooxygenase 2 inhibitor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cyclooxygenase 2 inhibitor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Cyclooxygenase 2 inhibitor is associated with the cancers and abnormal growths in the intestinal tract. These inhibitors could be helpful in reducing the occurrence of cancers and pre-cancerous growths. Approximately, 19,292,789 new cancer cases were diagnosed throughout the world, according to the Globocan 2020 fact sheet. The global burden of cancers could reach the value of 27.5 million new cancer cases by 2040, according to estimates from the International Agency for Research on Cancer (IARC).
The cyclooxygenase 2 inhibitor market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Cyclooxygenase 2 Inhibitor Market
A decline was witnessed in the diagnoses of cancer globally including, colorectal, lung, breast, esophageal pancreatic and gastric cancers. Centers for Disease Control and Prevention (CDC) along with numerous medical professional organizations recommended that cancer screening and other health prevention services to be postponed to secure the hospital infrastructure for the treatment of COVID-19 patients. The situation in the cyclooxygenase 2 inhibitor field is expected to gradually improve.
Global Cyclooxygenase 2 Inhibitor Market
环氧合酶 2 抑制剂市场根据药物类型、种类、适应症、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
药物类型
- 塞来昔布
- 罗非昔布
- 伐地昔布
- 氨氯地平
- 其他的
根据药物类型，环氧合酶2抑制剂市场分为塞来昔布、罗非昔布、伐地昔布、氨氯地平和其他。
类型
- 选择性 cox 2 抑制剂
- 非选择性 cox 2 抑制剂
根据类型，环氧合酶 2 抑制剂市场分为选择性 cox 2 抑制剂和非选择性 cox 2 抑制剂。
指征
- 骨关节炎
- 类风湿关节炎
- 其他的
根据适应症，环氧合酶2抑制剂市场分为骨关节炎、类风湿性关节炎和其他。
给药途径
- 口服
- 肠外
- 其他的
根据给药途径，环氧合酶 2 抑制剂市场分为口服、肠外和其他。
最终用户
- 医院
- 专科诊所
- 其他的
根据最终用户，环氧合酶 2 抑制剂市场分为医院、专科诊所和其他。
分销渠道
- 医院药房
- 零售药店
- 其他的
根据分销渠道，环氧合酶2抑制剂市场分为医院药房、零售药房和其他。
管道分析
一些环氧合酶 2 抑制剂 (COX-2 抑制剂) 被广泛用于单剂量治疗手术后疼痛。依托昔布被认为比其他止痛药更好，而塞来昔布似乎与布洛芬一样有用。辉瑞公司、拜耳公司、诺华公司和萨宾莎等是参与环氧合酶 2 抑制剂开发的制造商之一。
监管框架：环氧合酶 2 抑制剂市场
继罗非昔布于 2004 年被撤市后，美国唯一可用的环氧合酶 2 抑制剂是塞来昔布。伐地昔布也因心脏病发作和中风风险过度增加而被撤市。不过，FDA 已批准西乐葆用于治疗家族性腺瘤性息肉病 (FAP)，环氧合酶 2 抑制剂在乳腺癌研究中也显示出益处。
环氧合酶 2 抑制剂市场区域分析/见解
对环氧合酶 2 抑制剂市场进行了分析，并按国家、药物类型、种类、适应症、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
环氧合酶2抑制剂市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美地区对癌症的认识不断提高且相关研究不断增加，北美在环氧合酶 2 抑制剂市场占据主导地位。
由于该地区研发活动的激增，预计亚太地区在 2022 年至 2029 年的预测期内将实现高速增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
竞争格局和环氧合酶 2 抑制剂市场份额分析
环氧合酶 2 抑制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对环氧合酶 2 抑制剂市场的关注有关。
环氧合酶 2 抑制剂市场的一些主要参与者包括辉瑞公司、拜耳公司、诺华公司、萨宾莎公司、卡迪拉制药公司、迈兰公司、梯瓦制药工业有限公司、Alembic Pharmaceuticals Limited、Aurobindo Pharma、西普拉公司、Torrent Pharmaceuticals Ltd. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
